Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Covid 19 Anxiety in Endometriosis Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04337346
Recruitment Status : Completed
First Posted : April 7, 2020
Last Update Posted : May 20, 2020
Sponsor:
Information provided by (Responsible Party):
Pınar Yalcin bahat, Kanuni Sultan Suleyman Training and Research Hospital

Brief Summary:
It is aimed to measure the general anxiety and lifestyle information of endometriosis patients about covid 19 pandemic, to evaluate anxiety levels in this period.

Condition or disease
Endometriosis Covid19

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 80 participants
Observational Model: Case-Control
Time Perspective: Prospective
Target Follow-Up Duration: 20 Days
Official Title: Endometriosis Patients Covid 19 Anxiety
Actual Study Start Date : April 5, 2020
Actual Primary Completion Date : April 20, 2020
Actual Study Completion Date : April 25, 2020

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Covid 19 Anxiety levels in Endometriosis Patients [ Time Frame: 20 days ]
    The Beck Anxiety Inventory (BAI); it measures the frequency of anxiety symptoms experienced by the patient. It consists of 21 questions in total. Each item gets an increasing score between 0-3. The total score ranges from 0 - 63. The following guidelines are recommended for the interpretation of scores: 0 -9, normal or no anxiety; 10 -18, mild to moderate anxiety; 19 -29, moderate to severe anxiety; and 30 - 63, severe anxiety.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Evaluation of endometriosis patients anxiety and lifestyle during the covid 19 pandemic
Criteria

Inclusion Criteria:

  • endometriosis patients
  • no psychiatric illness
  • no antidepressant use

Exclusion Criteria:

  • women who had not endometriosis
  • no extra health conditions
  • women younger than 18 and older than 45

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04337346


Locations
Layout table for location information
Turkey
Pinar Yalcin Bahat
Istanbul, İ̇stanbul, Turkey, 34000
Sponsors and Collaborators
Kanuni Sultan Suleyman Training and Research Hospital
Layout table for additonal information
Responsible Party: Pınar Yalcin bahat, Principal Investigator, Kanuni Sultan Suleyman Training and Research Hospital
ClinicalTrials.gov Identifier: NCT04337346    
Other Study ID Numbers: endocovid19
First Posted: April 7, 2020    Key Record Dates
Last Update Posted: May 20, 2020
Last Verified: May 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Endometriosis